A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.
The study, published in the International Journal of Cancer, compared a new ‘epigenetics-based’ cervical cancer test with Pap smear and HPV tests, and investigated how well it predicted the development of cervical cancer up to five years in advance in a large study of women aged 25-65 in Canada.
As opposed to checking for patterns in the DNA genetic code itself that are indicative of the HPV virus, the new test looks at the naturally-occurring chemical markers that appear on top of the DNA, making up its ‘epigenetic profile’.
‘An enormous development’
Lead researcher Professor Attila Lorincz from Queen Mary’s Wolfson Institute of Preventive Medicine who also helped develop the world’s first test for HPV in 1988, said: “This is an enormous development. We’re not only astounded by how well this test detects cervical cancer, but it is the first time that anyone has proven the key role of epigenetics in the development of a major solid cancer using data from patients in the clinic. Epigenetic changes are what this cervical cancer test picks up and is exactly why it works so well.
“In contrast to what most researchers and clinicians are saying, we are seeing more and more evidence that it is in fact epigenetics, and not DNA mutations, that drives a whole range of early cancers, including cervical, anal, oropharyngeal, colon, and prostate.”
Screening to prevent cervical cancer is typically done through the Pap smear, which involves the collection, staining and microscopic examination of cells from the cervix. Unfortunately, the Pap smear can detect only around 50 per cent of cervical pre-cancers.
A much more accurate cervical screening method involves testing for the presence of DNA from the human papillomavirus (HPV) – the primary but indirect cause of cervical cancer. There are estimated to be around 10 million women in the UK who are infected by HPV.
However, the HPV test only identifies whether or not women are infected with a cancer-causing HPV, but not their actual risks of cancer, which remain quite low. This causes unnecessary worry for the majority of HPV-infected women who receive a positive result but will eventually clear the virus and not develop the disease.
Predicting a person’s risk of cervical cancer
The new test was significantly better than either the Pap smear or HPV test. It detected 100 per cent of the eight invasive cervical cancers that developed in the 15,744 women during the trial. In comparison, the Pap smear only detected 25 per cent of the cancers, and the HPV test detected 50 per cent.
The study also looked more closely at a subset of 257 HPV-positive women which were representatively selected from the large study. The new test detected 93 per cent of pre-cancerous lesions in those women, compared to 86 per cent detected using a combination of the Pap smear and HPV test, and 61 per cent detected using the Pap smear on its own.
Reducing the number of screening appointments needed
Professor Lorincz added: “This really is a huge advance in how to deal with HPV-infected women and men, numbering in the billions worldwide, and it is going to revolutionise screening.
“We were surprised by how well this new test can detect and predict early cervical cancers years in advance, with 100 per cent of cancers detected, including adenocarcinomas, which is a type of cervical cancer that is very difficult to detect. The new test is much better than anything offered in the UK at present but could take at least five years to be established.”
The authors say that using this test in the clinic would reduce the number of visits to the doctor and screening appointments, as high-grade disease would be detected from the start. They also say that if it was fully implemented, it would be cheaper than the Pap smear.
The Latest on: Cervical cancer
via Google News
The Latest on: Cervical cancer
- WHO Urges to Speed Up Efforts to Eliminate Cervical Cancer by 2030on September 6, 2019 at 7:54 pm
World Health Organization (WHO) has urged South-East Asian countries to speed up efforts to eliminate cervical cancer by 2030. "Countries need to expand vaccination, screening, detection and treatment ...
- WHO urges speedier efforts to eliminate cervical cancer by 2030on September 6, 2019 at 6:28 pm
New Delhi, Sep 6 : The World Health Organization (WHO) on Friday urged South-East Asian countries to accelerate efforts to eliminate cervical cancer by 2030. "Countries need to expand vaccination, ...
- Cervical Cancer Diagnostic Tests Market by Trends, Key Players, Segmentation, Forecast to 2026on September 6, 2019 at 5:36 am
Sep 06, 2019 (Global QYResearch via COMTEX) -- A new research report titled “Global Cervical Cancer Diagnostic Tests Market” successfully exhibits the complete scenario of the global and an individual ...
- Concerns raised as Yorkshire set to lose all its cervical cancer screening labson September 5, 2019 at 10:05 pm
Yorkshire will no longer have a cervical screening laboratory from December this year after NHS England made the decision to move the Leeds, Sheffield and York services to Gateshead. Unions have said ...
- Women’s motorcycle community rides to fight cervical canceron September 4, 2019 at 6:53 pm
SAN DIEGO (KUSI) – A group of 250 motorcycle riders are gathering together, all for a good cause. The “Moto Queens” are a group of women motorcycle riders who are raising money to help fight cervical ...
- Commentary: Collaboration Vital to Improving Treatment of Childhood Canceron September 4, 2019 at 5:00 pm
Another example is the technology that led to the HPV vaccine, which is given to adolescents to prevent cervical cancer and several other adult cancers. However, the greatest potential of the ...
- YouTuber Zoella films her smear test to raise awareness of cervical canceron September 4, 2019 at 2:39 pm
YOUTUBER Zoella filmed herself having a smear test to help raise awareness of cervical cancer. Zoe Sugg, 29, shared the footage with her 4.8million followers and said she wanted to encourage more ...
- Roadmap to Local Tumour Growth: Insights from Cervical Canceron September 4, 2019 at 2:07 am
Wide tumour excision is currently the standard approach to surgical treatment of solid cancers including carcinomas of the lower genital tract. This strategy is based on the premise that tumours ...
- Mum, 26, told cervical cancer symptoms were due to contraceptive injectionon September 3, 2019 at 4:12 am
A 26-year-old mum was told her cervical cancer symptoms were due to the contraceptive injection she was receiving. Alexandra Hodson had been experiencing key symptoms of the disease including pain ...
- A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-κB and TIMP3/MMP9 pathways in cervical cancer cellson September 1, 2019 at 3:09 pm
microRNAs (miRNAs) play an important role in carcinogenesis. Typically, miRNAs downregulate the target expression by binding to the 3′ UTR of mRNAs. However, recent studies have demonstrated that ...
via Bing News